Global Ranibizumab Market Size, Share, Trends and Forecast 2022-2030

Market Analysis and Insights: Global Ranibizumab Market
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.

The global Ranibizumab market size is projected to reach US$ 1647.3 million by 2028, from US$ 3449.6 million in 2021, at a CAGR of -9.9% during 2022-2028.

Global core ranibizumab manufacturers include Roche and Novartis etc. The Top 2 companies hold a share about 98%. North America is the largest market, with a share about 51%, followed by Europe and Asia Pacific with the share about 28% and 20%.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ranibizumab market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ranibizumab market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ranibizumab market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ranibizumab market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Ranibizumab market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Ranibizumab Breakdown Data by Type

Glass Vial

Prefilled Syringe

Ranibizumab Breakdown Data by Application

Wet AMD

Complications of Diabetes

RVO

Others

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Roche

Novartis

1 Report Business Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Ranibizumab Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Glass Vial

1.2.3 Prefilled Syringe

1.3 Market by Application

1.3.1 Global Ranibizumab Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Wet AMD

1.3.3 Complications of Diabetes

1.3.4 RVO

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Ranibizumab Market Perspective (2017-2028)

2.2 Ranibizumab Growth Trends by Region

2.2.1 Ranibizumab Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Ranibizumab Historic Market Size by Region (2017-2022)

2.2.3 Ranibizumab Forecasted Market Size by Region (2023-2028)

2.3 Ranibizumab Market Dynamics

2.3.1 Ranibizumab Industry Trends

2.3.2 Ranibizumab Market Drivers

2.3.3 Ranibizumab Market Challenges

2.3.4 Ranibizumab Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Ranibizumab Players by Revenue

3.1.1 Global Top Ranibizumab Players by Revenue (2017-2022)

3.1.2 Global Ranibizumab Revenue Market Share by Players (2017-2022)

3.2 Global Ranibizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Ranibizumab Revenue

3.4 Global Ranibizumab Market Concentration Ratio

3.4.1 Global Ranibizumab Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Ranibizumab Revenue in 2021

3.5 Ranibizumab Key Players Head office and Area Served

3.6 Key Players Ranibizumab Product Solution and Service

3.7 Date of Enter into Ranibizumab Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Ranibizumab Breakdown Data by Type

4.1 Global Ranibizumab Historic Market Size by Type (2017-2022)

4.2 Global Ranibizumab Forecasted Market Size by Type (2023-2028)

5 Ranibizumab Breakdown Data by Application

5.1 Global Ranibizumab Historic Market Size by Application (2017-2022)

5.2 Global Ranibizumab Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Ranibizumab Market Size (2017-2028)

6.2 North America Ranibizumab Market Size by Type

6.2.1 North America Ranibizumab Market Size by Type (2017-2022)

6.2.2 North America Ranibizumab Market Size by Type (2023-2028)

6.2.3 North America Ranibizumab Market Share by Type (2017-2028)

6.3 North America Ranibizumab Market Size by Application

6.3.1 North America Ranibizumab Market Size by Application (2017-2022)

6.3.2 North America Ranibizumab Market Size by Application (2023-2028)

6.3.3 North America Ranibizumab Market Share by Application (2017-2028)

6.4 North America Ranibizumab Market Size by Country

6.4.1 North America Ranibizumab Market Size by Country (2017-2022)

6.4.2 North America Ranibizumab Market Size by Country (2023-2028)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Ranibizumab Market Size (2017-2028)

7.2 Europe Ranibizumab Market Size by Type

7.2.1 Europe Ranibizumab Market Size by Type (2017-2022)

7.2.2 Europe Ranibizumab Market Size by Type (2023-2028)

7.2.3 Europe Ranibizumab Market Share by Type (2017-2028)

7.3 Europe Ranibizumab Market Size by Application

7.3.1 Europe Ranibizumab Market Size by Application (2017-2022)

7.3.2 Europe Ranibizumab Market Size by Application (2023-2028)

7.3.3 Europe Ranibizumab Market Share by Application (2017-2028)

7.4 Europe Ranibizumab Market Size by Country

7.4.1 Europe Ranibizumab Market Size by Country (2017-2022)

7.4.2 Europe Ranibizumab Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Ranibizumab Market Size (2017-2028)

8.2 Asia-Pacific Ranibizumab Market Size by Type

8.2.1 Asia-Pacific Ranibizumab Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Ranibizumab Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Ranibizumab Market Share by Type (2017-2028)

8.3 Asia-Pacific Ranibizumab Market Size by Application

8.3.1 Asia-Pacific Ranibizumab Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Ranibizumab Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Ranibizumab Market Share by Application (2017-2028)

8.4 Asia-Pacific Ranibizumab Market Size by Region

8.4.1 Asia-Pacific Ranibizumab Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Ranibizumab Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Ranibizumab Market Size (2017-2028)

9.2 Latin America Ranibizumab Market Size by Type

9.2.1 Latin America Ranibizumab Market Size by Type (2017-2022)

9.2.2 Latin America Ranibizumab Market Size by Type (2023-2028)

9.2.3 Latin America Ranibizumab Market Share by Type (2017-2028)

9.3 Latin America Ranibizumab Market Size by Application

9.3.1 Latin America Ranibizumab Market Size by Application (2017-2022)

9.3.2 Latin America Ranibizumab Market Size by Application (2023-2028)

9.3.3 Latin America Ranibizumab Market Share by Application (2017-2028)

9.4 Latin America Ranibizumab Market Size by Country

9.4.1 Latin America Ranibizumab Market Size by Country (2017-2022)

9.4.2 Latin America Ranibizumab Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Ranibizumab Market Size (2017-2028)

10.2 Middle East & Africa Ranibizumab Market Size by Type

10.2.1 Middle East & Africa Ranibizumab Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Ranibizumab Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Ranibizumab Market Share by Type (2017-2028)

10.3 Middle East & Africa Ranibizumab Market Size by Application

10.3.1 Middle East & Africa Ranibizumab Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Ranibizumab Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Ranibizumab Market Share by Application (2017-2028)

10.4 Middle East & Africa Ranibizumab Market Size by Country

10.4.1 Middle East & Africa Ranibizumab Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Ranibizumab Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Ranibizumab Introduction

11.1.4 Roche Revenue in Ranibizumab Business (2017-2022)

11.1.5 Roche Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Ranibizumab Introduction

11.2.4 Novartis Revenue in Ranibizumab Business (2017-2022)

11.2.5 Novartis Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer